187 related articles for article (PubMed ID: 1818058)
1. Determination of imipramine, desipramine and their hydroxy metabolites by reversed-phase chromatography with ultraviolet and coulometric detection.
Foglia JP; Sorisio D; Perel JM
J Chromatogr; 1991 Dec; 572(1-2):247-58. PubMed ID: 1818058
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous high-performance liquid chromatography-electrochemical detection determination of imipramine, desipramine, their 2-hydroxylated metabolites, and imipramine N-oxide in human plasma and urine: preliminary application to oxidation pharmacogenetics.
Koyama E; Kikuchi Y; Echizen H; Chiba K; Ishizaki T
Ther Drug Monit; 1993 Jun; 15(3):224-35. PubMed ID: 8333003
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of imipramine, desipramine and their 2- and 10-hydroxylated metabolites in human plasma and urine by high-performance liquid chromatography.
Chen AG; Wing YK; Chiu H; Lee S; Chen CN; Chan K
J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):153-8. PubMed ID: 9200529
[TBL] [Abstract][Full Text] [Related]
4. High-performance liquid chromatography of imipramine and six metabolites in human plasma and urine.
Nielsen KK; Brøsen K
J Chromatogr; 1993 Jan; 612(1):87-94. PubMed ID: 8454708
[TBL] [Abstract][Full Text] [Related]
5. Determination of imipramine and seven of its metabolites in human liver microsomes by a high-performance liquid chromatographic method.
Zeugin TB; Brosen K; Meyer UA
Anal Biochem; 1990 Aug; 189(1):99-102. PubMed ID: 2278396
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of imipramine, desipramine, and their 2-hydroxy metabolites in plasma by ion-pair reversed-phase high-performance liquid chromatography with amperometric detection.
Suckow RF; Cooper TB
J Pharm Sci; 1981 Mar; 70(3):257-61. PubMed ID: 7264887
[TBL] [Abstract][Full Text] [Related]
7. Quantitative mapping of metabolites of imipramine and desipramine in plasma samples by gas chromatographic-mass spectrometry.
Narasimhachari N; Saady J; Friedel RO
Biol Psychiatry; 1981 Oct; 16(10):937-44. PubMed ID: 7306616
[TBL] [Abstract][Full Text] [Related]
8. Active metabolites of imipramine and desipramine in man.
Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
[TBL] [Abstract][Full Text] [Related]
9. Determination of serum desipramine and 2-hydroxydesipramine for pharmacokinetic applications by HPLC with ultraviolet detection.
Kenney JT; Orsulak PJ; Kolodner RM; Burton ME
Clin Chem; 1989 Oct; 35(10):2134-6. PubMed ID: 2791284
[TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatographic assay for imipramine, desipramine, and their 2-hydroxylated metabolites.
Sutfin TA; Jusko WJ
J Pharm Sci; 1979 Jun; 68(6):703-5. PubMed ID: 458567
[TBL] [Abstract][Full Text] [Related]
11. Analysis of imipramine and three metabolites produced by isozyme CYP2D6 expressed in a human cell line.
Su P; Coutts RT; Baker GB; Daneshtalab M
Xenobiotica; 1993 Nov; 23(11):1289-98. PubMed ID: 8310712
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of imipramine and metabolites in 68 hospitalized children.
Preskorn SH; Bupp SJ; Weller EB; Weller RA
J Am Acad Child Adolesc Psychiatry; 1989 May; 28(3):373-5. PubMed ID: 2738003
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic monitoring of imipramine and desipramine by micellar liquid chromatography with direct injection and electrochemical detection.
Bose D; Martinavarro-Domínguez A; Gil-Agustí M; Carda-Broch S; Durgbanshi A; Capella-Peiró ME; Esteve-Romero J
Biomed Chromatogr; 2005 Jun; 19(5):343-9. PubMed ID: 15586373
[TBL] [Abstract][Full Text] [Related]
14. Steady-state levels of imipramine and its metabolites: significance of dose-dependent kinetics.
Brøsen K; Gram LF; Klysner R; Bech P
Eur J Clin Pharmacol; 1986; 30(1):43-9. PubMed ID: 3709631
[TBL] [Abstract][Full Text] [Related]
15. Imipramine metabolites in blood of patients during therapy and after overdose.
Gram LF; Bjerre M; Kragh-Sørensen P; Kvinesdal B; Molin J; Pedersen OL; Reisby N
Clin Pharmacol Ther; 1983 Mar; 33(3):335-42. PubMed ID: 6825388
[TBL] [Abstract][Full Text] [Related]
16. The analysis and disposition of imipramine and its active metabolites in man.
Sutfin TA; DeVane CL; Jusko WJ
Psychopharmacology (Berl); 1984; 82(4):310-7. PubMed ID: 6427820
[TBL] [Abstract][Full Text] [Related]
17. Urinary desipramine hydroxylation index and steady-state plasma concentrations of imipramine and desipramine.
Spina E; Arena A; Pisani F
Ther Drug Monit; 1987 Jun; 9(2):129-33. PubMed ID: 3617150
[TBL] [Abstract][Full Text] [Related]
18. Rapid microsample analysis of imipramine and desipramine by reversed-phase high-performance liquid chromatography with ultraviolet detection.
Yoo SD; Holladay JW; Fincher TK; Dewey MJ
J Chromatogr B Biomed Appl; 1995 Jun; 668(2):338-42. PubMed ID: 7581871
[TBL] [Abstract][Full Text] [Related]
19. Isolation and identification of the glucuronide conjugate of 2-hydroxydesipramine by preparative liquid chromatography.
Suckow RF; Cooper TB
J Chromatogr; 1988 Jun; 427(2):287-94. PubMed ID: 3410912
[TBL] [Abstract][Full Text] [Related]
20. Gas chromatographic-mass fragmentographic determation of "steady-state" plasma levels of imipramine and desipramine in chronically treated patients.
Belvedere G; Burti L; Frigerio A; Pantarotto C
J Chromatogr; 1975 Sep; 111(2):313-21. PubMed ID: 1159010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
